Akt and CHIP coregulate tau degradation through coordinated interactions

Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B

Cross, D. A. E., Alessi, D. R., Cohen, P., Andjelkovich, M., & Hemmings, B. A. (1995) · Nature · doi:10.1038/378785a0 · Cited by 5,244 · see citing works

Akt1/PKBα Is Required for Normal Growth but Dispensable for Maintenance of Glucose Homeostasis in Mice

Cho, H., Thorvaldsen, J. L., Chu, Q., Feng, F., & Birnbaum, M. J. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.c100462200 · Cited by 959 · see citing works

Identification of CHIP, a Novel Tetratricopeptide Repeat-Containing Protein That Interacts with Heat Shock Proteins and Negatively Regulates Chaperone Functions

Ballinger, C. A., Connell, P. M., Wu, Y., Hu, Z., Thompson, L. J., Yin, L.-Y., & Patterson, C. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.6.4535 · Cited by 943 · see citing works

CHIP and Hsp70 regulate tau ubiquitination, degradation and aggregation

Petrucelli, L. (2004) · Human Molecular Genetics · doi:10.1093/hmg/ddh083 · Cited by 735 · see citing works

Regulation of Longevity in Caenorhabditis elegans by Heat Shock Factor and Molecular Chaperones

Morley, J. F., & Morimoto, R. I. (2003) · Molecular Biology of the Cell · doi:10.1091/mbc.e03-07-0532 · Cited by 725 · see citing works

Hsp90 inhibitors as novel cancer chemotherapeutic agents

Neckers, L. (2002) · Trends in Molecular Medicine · doi:10.1016/s1471-4914(02)02316-x · Cited by 677 · see citing works

The high-affinity HSP90–CHIP complex recognizes and selectively degrades phosphorylated tau client proteins

Dickey, C. A., Kamal, A., Lundgren, K., Klosak, N., Bailey, R. M., Dunmore, J., Ash, P., Shoraka, S., Zlatkovic, J., Eckman, C. B., et al. (2007) · Journal of Clinical Investigation · doi:10.1172/jci29715 · Cited by 642 · see citing works

Akt Forms an Intracellular Complex with Heat Shock Protein 90 (Hsp90) and Cdc37 and Is Destabilized by Inhibitors of Hsp90 Function

Basso, A. D., Solit, D. B., Chiosis, G., Giri, B., Tsichlis, P., & Rosen, N. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m206322200 · Cited by 628 · see citing works

Timing Requirements for Insulin/IGF-1 Signaling in C. elegans

Dillin, A., Crawford, D. K., & Kenyon, C. J. (2002) · Science · doi:10.1126/science.1074240 · Cited by 467 · see citing works

CHIP-mediated stress recovery by sequential ubiquitination of substrates and Hsp70

Qian, S., McDonough, H., Boellmann, F., Cyr, D., & Patterson, C. (2006) · Nature · doi:10.1038/nature04600 · Cited by 369 · see citing works

PAR-1 Kinase Plays an Initiator Role in a Temporally Ordered Phosphorylation Process that Confers Tau Toxicity in Drosophila

Nishimura, I., Yang, Y., & Lu, B. (2004) · Cell · doi:10.1016/s0092-8674(04)00170-9 · Cited by 324 · see citing works

CHIP activates HSF1 and confers protection against apoptosis and cellular stress

Dai, Q., Zhang, C., Wu, Y., McDonough, H., Whaley, R. A., Godfrey, V., Li, H., Madamanchi, N. R., Xu, W., Neckers, L., et al. (2003) · The EMBO Journal · doi:10.1093/emboj/cdg529 · Cited by 320 · see citing works

Deletion of the Ubiquitin Ligase CHIP Leads to the Accumulation, But Not the Aggregation, of Both Endogenous Phospho- and Caspase-3-Cleaved Tau Species

Dickey, C. A., Yue, M., Lin, W.-L., Dickson, D. W., Dunmore, J. H., Lee, W. C., Zehr, C., West, G., Cao, S., Clark, A. M. K., et al. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.0746-06.2006 · Cited by 248 · see citing works

HEREDITARY LEUCODYSTROPHY IN THE MOUSE: THE NEW MUTANT TWITCHER

Duchen, L. W., Eicher, E. M., Jacobs, J. M., Scaravilli, F., & TEIXEIRA, F. (1980) · Brain · doi:10.1093/brain/103.3.695 · Cited by 243 · see citing works

Selectively Reduced Expression of Synaptic Plasticity-Related Genes in Amyloid Precursor Protein + Presenilin-1 Transgenic Mice

Dickey, C. A., Loring, J. F., Montgomery, J., Gordon, M. N., Eastman, P. S., & Morgan, D. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-12-05219.2003 · Cited by 242 · see citing works

HSP induction mediates selective clearance of tau phosphorylated at proline-directed Ser/Thr sites but not KXGS (MARK) sites

Dickey, C. A., Dunmore, J., Lu, B., Wang, J., Lee, W. C., Kamal, A., Burrows, F., Eckman, C., Hutton, M., & Petrucelli, L. (2006) · The FASEB Journal · doi:10.1096/fj.05-5343fje · Cited by 160 · see citing works

Mechanism of neurodegenerative disease: role of the ubiquitin proteasome system

Petrucelli, L., & Dawson, T. M. (2004) · Annals of Medicine · doi:10.1080/07853890410031948 · Cited by 130 · see citing works

Development of a High Throughput Drug Screening Assay for the Detection of Changes in Tau Levels - Proof of Concept with HSP90 inhibitors

Dickey, C. A., Eriksen, J. L., Kamal, A., Burrows, F. J., Kasibhatla, S. R., Eckman, C. B., Hutton, M., & Petrucelli, L. (2005) · Current Alzheimer Research · doi:10.2174/1567205053585927 · Cited by 66 · see citing works

The Sch9 protein kinase regulates Hsp90 chaperone complex signal transduction activity in vivo

Morano, K. A., & Thiele, D. J. (1999) · The EMBO Journal · doi:10.1093/emboj/18.21.5953 · Cited by 62 · see citing works

Expression of mRNA for Akt, serine-threonine protein kinase, in the brain during development and its transient enhancement following axotomy of hypoglossal nerve

Owada, Y., Utsunomiya, A., Yoshimoto, T., & Kondo, H. (1997) · Journal of Molecular Neuroscience · doi:10.1007/bf02789392 · Cited by 56 · see citing works

Current strategies for the treatment of Alzheimer’s disease and other tauopathies

Dickey, C. A., & Petrucelli, L. (2006) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.10.5.665 · Cited by 24 · see citing works

Tau in Alzheimer Disease and Related Tauopathies

Iqbal, K., Liu, F., Gong, C., & Grundke, I. (2010) · Current Alzheimer Research · doi:10.2174/156720510793611592 · Cited by 1,122 · see citing works

The role of protein clearance mechanisms in organismal ageing and age-related diseases

Vı́lchez, D., Sáez, I., & Dillin, A. G. (2014) · Nature Communications · doi:10.1038/ncomms6659 · Cited by 684 · see citing works

Mechanisms of tau-induced neurodegeneration

Iqbal, K., Liu, F., Gong, C.-X., Alonso, A. D. C., & Grundke-Iqbal, I. (2009) · Acta Neuropathologica · doi:10.1007/s00401-009-0486-3 · Cited by 628 · see citing works

Regulation of proteasome activity in health and disease

Schmidt, M., & Finley, D. J. (2013) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2013.08.012 · Cited by 461 · see citing works

Tau Protein Modifications and Interactions: Their Role in Function and Dysfunction

Mietelska‐Porowska, A., Wasik, U., Goras, M., Filipek, A., & Niewiadomska, G. (2014) · International Journal of Molecular Sciences · doi:10.3390/ijms15034671 · Cited by 407 · see citing works

Ubiquitination-Proteasome System (UPS) and Autophagy Two Main Protein Degradation Machineries in Response to Cell Stress

Li, Y.-N., Li, S.-J., & Wu, H.-J. (2022) · Cells · doi:10.3390/cells11050851 · Cited by 344 · see citing works

Selective clearance of aberrant tau proteins and rescue of neurotoxicity by transcription factor EB

Polito, V. A., Li, H., Martini‐Stoica, H., Wang, B., Li, Y., Xu, Y., Swartzlander, D. B., Palmieri, M., di Ronza, A., Lee, V. M. ‐., et al. (2014) · EMBO Molecular Medicine · doi:10.15252/emmm.201303671 · Cited by 351 · see citing works

Hsp90: Structure and Function

Jackson, S. (2012) · Topics in current chemistry · doi:10.1007/128_2012_356 · Cited by 334 · see citing works

The Mechanistic Links Between Proteasome Activity, Aging and Agerelated Diseases

Sáez, I., & Vı́lchez, D. (2014) · Current Genomics · doi:10.2174/138920291501140306113344 · Cited by 318 · see citing works

Structure, Function, and Regulation of the Hsp90 MachineryPreprint

Biebl, M. M., & Büchner, J. (2019) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a034017 · Cited by 308 · see citing works

Acetylation of the KXGS motifs in tau is a critical determinant in modulation of tau aggregation and clearance

Cook, C. N., Carlomagno, Y., Gendron, T. F., Dunmore, J. H., Scheffel, K., Stetler, C. T., Davis, M., Dickson, D. W., Jarpe, M. B., Deture, M. A., et al. (2013) · Human Molecular Genetics · doi:10.1093/hmg/ddt402 · Cited by 309 · see citing works

Conformational dynamics of the molecular chaperone Hsp90

Krukenberg, K. A., Street, T. O., Lavery, L. A., & Agard, D. A. (2011) · Quarterly Reviews of Biophysics · doi:10.1017/s0033583510000314 · Cited by 308 · see citing works

Heat shock proteins: Cellular and molecular mechanisms in the central nervous system

Stetler, R. A., Gan, Y., Zhang, W., Liou, A. K. F., Gao, Y., Cao, G., & Chen, J. (2010) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2010.05.002 · Cited by 306 · see citing works

Autophagic degradation of tau in primary neurons and its enhancement by trehalose

Krüger, U., Wang, Y., Kumar, S., & Mandelkow, E.-M. (2012) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2011.11.009 · Cited by 297 · see citing works

Chemical Manipulation of Hsp70 ATPase Activity Regulates Tau Stability

Jinwal, U. K., Miyata, Y., Koren, J., Jones, J. R., Trotter, J. H., Chang, L., O’Leary, J. C., Morgan, D., Lee, D. C., Shults, C. L., et al. (2009) · Journal of Neuroscience · doi:10.1523/jneurosci.3345-09.2009 · Cited by 231 · see citing works

The tau of MARK: a polarized view of the cytoskeleton

Matenia, D., & Mandelkow, E. (2009) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2009.03.008 · Cited by 228 · see citing works

Broad action of Hsp90 as a host chaperone required for viral replication

Geller, R., Taguwa, S., & Frydman, J. (2011) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2011.11.007 · Cited by 220 · see citing works

The cellular and molecular processes associated with scopolamine-induced memory deficit: A model of Alzheimer's biomarkers

Tang, K. S. (2019) · Life Sciences · doi:10.1016/j.lfs.2019.116695 · Cited by 217 · see citing works

The Hsp90 cochaperone, FKBP51, increases Tau stability and polymerizes microtubules

Jinwal, U. K., Koren, J., Borysov, S. I., Schmid, A. B., Abisambra, J. F., Blair, L. J., Johnson, A. G., Jones, J. R., Shults, C. L., O'Leary, J. C., et al. (2010) · The Journal of Neuroscience · doi:10.1523/jneurosci.4815-09.2010 · Cited by 214 · see citing works

Curcumin Suppresses Soluble Tau Dimers and Corrects Molecular Chaperone, Synaptic, and Behavioral Deficits in Aged Human Tau Transgenic Mice

Ma, Q., Zuo, X., Yang, F., Ubeda, O. J., Gant, D. J., Alaverdyan, M., Teng, E., Hu, S., Chen, P., Maiti, P., et al. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.393751 · Cited by 212 · see citing works

Role of the ubiquitin proteasome system in Alzheimer's disease

Upadhya, S. C., & Hegde, A. N. (2007) · BMC Biochemistry · doi:10.1186/1471-2091-8-s1-s12 · Cited by 184 · see citing works

Akt/PKB: one kinase, many modifications

Risso, G. J., Blaustein, M., Pozzi, B., Mammi, P., & Srebrow, A. (2015) · Biochemical Journal · doi:10.1042/bj20150041 · Cited by 179 · see citing works

Allostery in the Hsp70 Chaperone Proteins

Zuiderweg, E. R. P., Bertelsen, E. B., Rousaki, A., Mayer, M. P., Gestwicki, J. E., & Ahmad, A. (2012) · Topics in current chemistry · doi:10.1007/128_2012_323 · Cited by 164 · see citing works

The ubiquitin ligase CHIP regulates c-Myc stability and transcriptional activity

Paul, I., Ahmed, S. F., Bhowmik, A., Deb, S., & Ghosh, M. K. (2012) · Oncogene · doi:10.1038/onc.2012.144 · Cited by 159 · see citing works

Relationship Between Tau Pathology and Neuroinflammation in Alzheimer's Disease

Metcalfe, M., & Figueiredo‐Pereira, M. E. (2010) · Mount Sinai Journal of Medicine A Journal of Translational and Personalized Medicine · doi:10.1002/msj.20163 · Cited by 158 · see citing works

Reduction of Nuak1 Decreases Tau and Reverses Phenotypes in a Tauopathy Mouse Model

Lasagna‐Reeves, C. A., de Haro, M., Hao, S., Park, J., Rousseaux, M. W. C., Al‐Ramahi, I., Jafar‐Nejad, P., Vilanova-Velez, L., See, L., Maio, A. D., et al. (2016) · Neuron · doi:10.1016/j.neuron.2016.09.022 · Cited by 156 · see citing works

The E3 Ligase TTC3 Facilitates Ubiquitination and Degradation of Phosphorylated Akt

Suizu, F., Hiramuki, Y., Okumura, F., Matsuda, M., Okumura, A. J., Hirata, N., Narita, M., Kohno, T., Yokota, J., Bohgaki, M., et al. (2009) · Developmental Cell · doi:10.1016/j.devcel.2009.09.007 · Cited by 148 · see citing works

An acetylation–phosphorylation switch that regulates tau aggregation propensity and function

Carlomagno, Y., Chung, D.-E. C., Yue, M., Castanedes-Casey, M., Madden, B. J., Dunmore, J., Tong, J., DeTure, M., Dickson, D. W., Petrucelli, L., et al. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.m117.794602 · Cited by 143 · see citing works

X-linked ubiquitin-specific peptidase 11 increases tauopathy vulnerability in women

Yan, Y., Wang, X., Chaput, D., Shin, M.-K., Koh, Y., Gan, L., Pieper, A. A., Woo, J.-A. A., & Kang, D. E. (2022) · Cell · doi:10.1016/j.cell.2022.09.002 · Cited by 144 · see citing works

ZNRF1 promotes Wallerian degeneration by degrading AKT to induce GSK3B-dependent CRMP2 phosphorylation

Wakatsuki, S., Saitoh, F., & Araki, T. (2011) · Nature Cell Biology · doi:10.1038/ncb2373 · Cited by 140 · see citing works

Chaperone signalling complexes in Alzheimer's disease

Koren, J., Jinwal, U. K., Lee, D. C., Jones, J. R., Shults, C. L., Johnson, A. G., Anderson, L. J., & Dickey, C. A. (2008) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2008.00557.x · Cited by 140 · see citing works

Lysine-Directed Post-translational Modifications of Tau Protein in Alzheimer's Disease and Related Tauopathies

Kontaxi, C., Piccardo, P., & Gill, A. C. (2017) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2017.00056 · Cited by 138 · see citing works

Acetylation: a new key to unlock tau’s role in neurodegeneration

Cook, C. N., Stankowski, J. N., Carlomagno, Y., Stetler, C. T., & Petrucelli, L. (2014) · Alzheimer s Research & Therapy · doi:10.1186/alzrt259 · Cited by 133 · see citing works

New Insights into Protein Kinase B/Akt Signaling: Role of Localized Akt Activation and Compartment-Specific Target Proteins for the Cellular Radiation Response

Szymonowicz, K., Oeck, S., Malewicz, N. M., & Jendrossek, V. (2018) · Cancers · doi:10.3390/cancers10030078 · Cited by 134 · see citing works

Hsp90 regulates tau pathology through co-chaperone complexes in Alzheimer's disease

Salminen, A., Ojala, J. O., Kaarniranta, K., Hiltunen, M., & Soininen, H. S. (2010) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2010.10.006 · Cited by 129 · see citing works

Pharmacological Targeting of the Hsp70 Chaperone

Patury, S., Miyata, Y., & Gestwicki, J. E. (2009) · Current Topics in Medicinal Chemistry · doi:10.2174/156802609789895674 · Cited by 128 · see citing works

Akt: a key transducer in cancer

Tsai, P., Lai, Y., Manne, R., Tsai, Y.-S., Sarbassov, D. D., & Lin, H. (2022) · Journal of Biomedical Science · doi:10.1186/s12929-022-00860-9 · Cited by 131 · see citing works

Dual modification of Alzheimer’s disease PHF-tau protein by lysine methylation and ubiquitylation: a mass spectrometry approach

Thomas, S. N., Funk, K. E., Wan, Y., Liao, Z., Davies, P., Kuret, J., & Yang, A. J. (2012) · Acta Neuropathologica · doi:10.1007/s00401-011-0893-0 · Cited by 123 · see citing works

Ubiquitin-dependent Regulation of Phospho-AKT Dynamics by the Ubiquitin E3 Ligase, NEDD4-1, in the Insulin-like Growth Factor-1 Response

Fan, C.-D., Lum, M. A., Xu, C., Black, J. D., & Wang, X. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.416339 · Cited by 123 · see citing works

The role of heat shock proteins and co-chaperones in heart failure

Ranek, M. J., Stachowski, M. J., Kirk, J. A., & Willis, M. S. (2017) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2016.0530 · Cited by 121 · see citing works

Hsp90 and Its Co-Chaperones in Neurodegenerative Diseases

Bohush, A., Bieganowski, P., & Filipek, A. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20204976 · Cited by 120 · see citing works

Branched-Chain Amino Acids Exacerbate Obesity-Related Hepatic Glucose and Lipid Metabolic Disorders via Attenuating Akt2 Signaling

Zhao, H., Zhang, F., Sun, D., Wang, X., Zhang, X., Zhang, J., Yan, F., Huang, C., Xie, H., Lin, C., et al. (2020) · Diabetes · doi:10.2337/db19-0920 · Cited by 117 · see citing works

Functional genomic screen and network analysis reveal novel modifiers of tauopathy dissociated from tau phosphorylation

Ambegaokar, S. S., & Jackson, G. R. (2011) · Human Molecular Genetics · doi:10.1093/hmg/ddr432 · Cited by 113 · see citing works

K63-Linked Ubiquitination in Kinase Activation and Cancer

Wang, G., Gao, Y., Li, L., Jin, G., Cai, Z., Chao, J. I., & Lin, H.-K. (2012) · Frontiers in Oncology · doi:10.3389/fonc.2012.00005 · Cited by 108 · see citing works

The role of the ubiquitin proteasome system in Alzheimer's disease

Riederer, B. M., Leuba, G., Vernay, A., & Riederer, I. M. (2011) · Experimental Biology and Medicine · doi:10.1258/ebm.2010.010327 · Cited by 110 · see citing works

Structure and pro-toxic mechanism of the human Hsp90/PPIase/Tau complex

Oroz, J., Chang, B. J., Wysoczanski, P., Lee, C.-T., Pérez-Lara, Á., Chakraborty, P., Hofele, R. V., Baker, J. D., Blair, L. J., Biernat, J., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-06880-0 · Cited by 100 · see citing works

Akt is negatively regulated by the MULAN E3 ligase

Bae, S., Kim, S. Y., Jung, J. H., Yoon, Y., Cha, H. J., Lee, H., Kim, K., Kim, J., An, I.-S., Kim, J., et al. (2012) · Cell Research · doi:10.1038/cr.2012.38 · Cited by 106 · see citing works

Mutant ASXL1 induces age-related expansion of phenotypic hematopoietic stem cells through activation of Akt/mTOR pathway

Fujino, T., Goyama, S., Sugiura, Y., Inoue, D., Asada, S., Yamasaki, S., Matsumoto, A., Yamaguchi, K., Isobe, Y., Tsuchiya, A., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-22053-y · Cited by 101 · see citing works

Alzheimer’s Disease: Mechanism and Approach to Cell Therapy

Amemori, T., Jendelová, P., Růžička, J., Urdzíková, L. M., & Syková, E. (2015) · International Journal of Molecular Sciences · doi:10.3390/ijms161125961 · Cited by 102 · see citing works

Emerging role of Lys-63 ubiquitination in protein kinase and phosphatase activation and cancer development

Yang, W.-L., Zhang, X., & Lin, H.-K. (2010) · Oncogene · doi:10.1038/onc.2010.190 · Cited by 101 · see citing works

Differential metformin dose-dependent effects on cognition in rats: role of Akt

Mostafa, D. K., Ismail, C. A., & Ghareeb, D. A. (2016) · Psychopharmacology · doi:10.1007/s00213-016-4301-2 · Cited by 101 · see citing works

Heat Shock Protein 90 in Alzheimer’s Disease

Ou, J.-R., Tan, M., Xie, A., Yu, J., & Tan, L. (2014) · BioMed Research International · doi:10.1155/2014/796869 · Cited by 99 · see citing works

Mediators of tau phosphorylation in the pathogenesis of Alzheimer’s disease

Hanger, D. P., Seereeram, A., & Noble, W. (2009) · Expert Review of Neurotherapeutics · doi:10.1586/ern.09.104 · Cited by 98 · see citing works

CHIP: A Co-chaperone for Degradation by the Proteasome

Edkins, A. L. (2014) · Sub-cellular biochemistry/Subcellular biochemistry · doi:10.1007/978-3-319-11731-7_11 · Cited by 97 · see citing works

The Ubiquitin-Proteasome System Meets Angiogenesis

Rahimi, N. (2012) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-11-0555 · Cited by 96 · see citing works

Hsc70 Rapidly Engages Tau after Microtubule Destabilization

Jinwal, U. K., O’Leary, J. C., Borysov, S. I., Jones, J. R., Li, Q., Koren, J., Abisambra, J. F., Vestal, G. D., Lawson, L. Y., Johnson, A. G., et al. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.113753 · Cited by 97 · see citing works

The links between AKT and two intracellular proteolytic cascades: Ubiquitination and autophagy

Noguchi, M., Hirata, N., & Suizu, F. (2014) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2014.07.013 · Cited by 96 · see citing works

Autophagy, its mechanisms and regulation: Implications in neurodegenerative diseases

Moloudizargari, M., Asghari, M. H., Ghobadi, E., Fallah, M., Rasouli, S., & Abdollahi, M. R. (2017) · Ageing Research Reviews · doi:10.1016/j.arr.2017.09.005 · Cited by 93 · see citing works

To Fold or Not to Fold: Modulation and Consequences of Hsp90 Inhibition

Peterson, L. B., & Blagg, B. S. J. (2009) · Future Medicinal Chemistry · doi:10.4155/fmc.09.17 · Cited by 88 · see citing works

Modelling the Role of the Hsp70/Hsp90 System in the Maintenance of Protein Homeostasis

Proctor, C. J., & Lorimer, I. A. J. (2011) · PLoS ONE · doi:10.1371/journal.pone.0022038 · Cited by 87 · see citing works

Aging Analysis Reveals Slowed Tau Turnover and Enhanced Stress Response in a Mouse Model of Tauopathy

Dickey, C. A., Kraft, C., Jinwal, U. K., Koren, J., Johnson, A. G., Anderson, L. C., Lebson, L. A., Lee, D. C., Dickson, D. W., de Silva, R., et al. (2008) · American Journal Of Pathology · doi:10.2353/ajpath.2009.080764 · Cited by 85 · see citing works

Facilitating Akt Clearance via Manipulation of Hsp70 Activity and Levels

Koren, J., Jinwal, U. K., Jin, Y., O’Leary, J. C., Jones, J. R., Johnson, A. G., Blair, L. J., Abisambra, J. F., Chang, L., Miyata, Y., et al. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.057208 · Cited by 85 · see citing works

E2 Conjugating Enzyme Selectivity and Requirements for Function of the E3 Ubiquitin Ligase CHIP

Soss, S. E., Yue, Y., Dhe‐Paganon, S., & Chazin, W. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.224006 · Cited by 84 · see citing works

Clinical neuropathology practice guide 5-2013: markers of neuronal maturation

Sarnat, H. B. (2013) · Clinical Neuropathology · doi:10.5414/np300638 · Cited by 84 · see citing works

Aβ exacerbates the neuronal dysfunction caused by human tau expression in a Drosophila model of Alzheimer's disease

Folwell, J., Cowan, C. M., Ubhi, K. K., Shiabh, H., Newman, T. A., Shepherd, D., & Mudher, A. (2010) · Experimental Neurology · doi:10.1016/j.expneurol.2009.09.014 · Cited by 83 · see citing works

Tau deposition drives neuropathological, inflammatory and behavioral abnormalities independently of neuronal loss in a novel mouse model

Cook, C., Kang, S. S., Carlomagno, Y., Lin, W.-L., Yue, M., Kurti, A., Shinohara, M., Jansen-West, K., Perkerson, E., Castanedes-Casey, M., et al. (2015) · Human Molecular Genetics · doi:10.1093/hmg/ddv336 · Cited by 82 · see citing works

The Hsp90 Kinase Co-chaperone Cdc37 Regulates Tau Stability and Phosphorylation Dynamics

Jinwal, U. K., Trotter, J. H., Abisambra, J. F., Koren, J., Lawson, L. Y., Vestal, G. D., O’Leary, J. C., Johnson, A. G., Jin, Y., Jones, J. R., et al. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.182493 · Cited by 82 · see citing works

GSK3 and p53 - is there a link in Alzheimer's disease?

Proctor, C. J., & Gray, D. A. (2010) · Molecular Neurodegeneration · doi:10.1186/1750-1326-5-7 · Cited by 80 · see citing works

Imbalances in the Hsp90 Chaperone Machinery: Implications for Tauopathies

Shelton, L. B., Koren, J., & Blair, L. J. (2017) · Frontiers in Neuroscience · doi:10.3389/fnins.2017.00724 · Cited by 78 · see citing works

Rho-kinase ROCK inhibitors reduce oligomeric tau protein

Hamano, T., Shirafuji, N., Yen, S.-H., Yoshida, H., Kanaan, N. M., Hayashi, K., Ikawa, M., Yamamura, O., Fujita, Y., Kuriyama, M., et al. (2020) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2019.12.009 · Cited by 76 · see citing works

CHIP Represses Myocardin-Induced Smooth Muscle Cell Differentiation via Ubiquitin-Mediated Proteasomal Degradation

Xie, P., Fan, Y., Zhang, H., Zhang, Y., She, M., Gu, D., Patterson, C., & Li, H. (2009) · Molecular and Cellular Biology · doi:10.1128/mcb.01737-08 · Cited by 75 · see citing works

CHIP as a therapeutic target for neurological diseases

Zhang, S., Hu, Z., Mao, C., Shi, C., & Xu, Y. (2020) · Cell Death and Disease · doi:10.1038/s41419-020-02953-5 · Cited by 72 · see citing works

A Decade of Boon or Burden: What Has the CHIP Ever Done for Cellular Protein Quality Control Mechanism Implicated in Neurodegeneration and Aging?

Joshi, V., Amanullah, A., Upadhyay, A., Mishra, R., Kumar, A., & Mishra, A. (2016) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2016.00093 · Cited by 74 · see citing works

Advances in Therapeutics for Neurodegenerative Tauopathies: Moving toward the Specific Targeting of the Most Toxic Tau Species

Gerson, J. E., Castillo‐Carranza, D. L., & Kayed, R. (2014) · ACS Chemical Neuroscience · doi:10.1021/cn500143n · Cited by 73 · see citing works

Linking pathways in the developing and aging brain with neurodegeneration

Kovács, G. G., Adle‐Biassette, H., Milenković, I., Cipriani, S., van Scheppingen, J., & Aronica, E. (2014) · Neuroscience · doi:10.1016/j.neuroscience.2014.03.045 · Cited by 67 · see citing works

The cargo receptor SQSTM1 ameliorates neurofibrillary tangle pathology and spreading through selective targeting of pathological MAPT (microtubule associated protein tau)

Xu, Y., Zhang, S., & Zheng, H. (2018) · Autophagy · doi:10.1080/15548627.2018.1532258 · Cited by 68 · see citing works

Cdk5 at crossroads of protein oligomerization in neurodegenerative diseases: facts and hypotheses

Wilkaniec, A., Czapski, G. A., & Adamczyk, A. (2015) · Journal of Neurochemistry · doi:10.1111/jnc.13365 · Cited by 68 · see citing works

Tau Phosphorylation, Molecular Chaperones, and Ubiquitin E3 Ligase: Clinical Relevance in Alzheimer's Disease

Kumar, P., Jha, N. K., Jha, S. K., Ramani, K., & Ambasta, R. K. (2014) · Journal of Alzheimer s Disease · doi:10.3233/jad-140933 · Cited by 67 · see citing works

Identifying the substrate proteins of U-box E3s E4B and CHIP by orthogonal ubiquitin transfer

Bhuripanyo, K., Wang, Y., Liu, X., Zhou, L., Liu, R., Duong, D. M., Zhao, B., Bi, Y., Zhou, H., Chen, G., et al. (2018) · Science Advances · doi:10.1126/sciadv.1701393 · Cited by 66 · see citing works

Integrating the Alzheimer's Disease Proteome and Transcriptome: A Comprehensive Network Model of a Complex Disease

Hallock, P., & Thomas, M. A. (2012) · OMICS A Journal of Integrative Biology · doi:10.1089/omi.2011.0054 · Cited by 64 · see citing works

Integrative Brain Transcriptome Analysis Links Complement Component 4 and HSPA2 to the APOE ε2 Protective Effect in Alzheimer Disease

Panitch, R., Hu, J.-M., Chung, J., Zhu, C.-C., Meng, G., Xia, W., Bennett, D. A., Lunetta, K., Ikezu, T., Au, R., et al. (2020) · Molecular Psychiatry · doi:10.1038/s41380-021-01266-z · Cited by 50 · see citing works

Molecular Chaperones and Regulation of Tau Quality Control: Strategies for Drug Discovery in Tauopathies

Miyata, Y., Koren, J., Kiray, J., Dickey, C. A., & Gestwicki, J. E. (2011) · Future Medicinal Chemistry · doi:10.4155/fmc.11.88 · Cited by 64 · see citing works

Cross‐functional E3 ligases Parkin and C‐terminus Hsp70‐interacting protein in neurodegenerative disorders

Kumar, P., Pradhan, K., Ramani, K., Ambasta, R. K., & Querfurth, H. W. (2011) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2011.07588.x · Cited by 61 · see citing works

Growth Hormone Receptor Regulation in Cancer and Chronic Diseases

Strous, G. J., Almeida, A. D. S., Putters, J., Schantl, J., Sędek, M., Slotman, J. A., Nespital, T., Hassink, G. C., & Mol, J. A. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.597573 · Cited by 61 · see citing works

Ubiquitination and cysteine nitrosylation during aging and Alzheimer's disease

Riederer, I. M., Schiffrin, M., Kövari, E., Bouras, C., & Riederer, B. M. (2009) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2009.04.018 · Cited by 60 · see citing works

Hyperforin attenuates aluminum-induced Aβ production and Tau phosphorylation via regulating Akt/GSK-3β signaling pathway in PC12 cells

Huang, W., Chen, P., Yu, K., Han, Y., Song, M., & Li, Y. (2017) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2017.09.114 · Cited by 59 · see citing works

Severe amygdala dysfunction in a MAPT transgenic mouse model of frontotemporal dementia

Cook, C. N., Dunmore, J. H., Murray, M. E., Scheffel, K., Shukoor, N., Tong, J., Castanedes‐Casey, M., Phillips, V. R., Rousseau, L., Penuliar, M. S., et al. (2014) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2013.12.023 · Cited by 59 · see citing works

Chaperone-assisted E3 ligase CHIP: A double agent in cancer

Kumar, S., Basu, M., & Ghosh, M. K. (2021) · Genes & Diseases · doi:10.1016/j.gendis.2021.08.003 · Cited by 57 · see citing works

Interactions of the Proteasomal System with Chaperones

Kästle, M., & Grune, T. (2012) · Progress in molecular biology and translational science · doi:10.1016/b978-0-12-397863-9.00004-3 · Cited by 56 · see citing works

Akt phosphorylation at Thr308 and Ser473 is required for CHIP-mediated ubiquitination of the kinase

Su, C.-H., Wang, C.-Y., Lan, K., Li, C., Chao, Y., Lin, H.-C., Lee, S., & Lee, W. (2011) · Cellular Signalling · doi:10.1016/j.cellsig.2011.06.018 · Cited by 57 · see citing works

Cell injury and Premature Neurodegeneration in Focal Malformations of Cortical Development

Iyer, A. M., Prabowo, A. S., Anink, J. J., Spliet, W. G. M., van Rijen, P. C., & Aronica, E. (2013) · Brain Pathology · doi:10.1111/bpa.12060 · Cited by 56 · see citing works

Protection against doxorubicin-induced myocardial dysfunction in mice by cardiac-specific expression of carboxyl terminus of hsp70-interacting protein

Wang, L., Zhang, T., Zhang, Y., Bi, H.-L., Guan, X., Wang, H., Wang, X., Du, J., Xia, Y., & Li, H. (2016) · Scientific Reports · doi:10.1038/srep28399 · Cited by 55 · see citing works

Copper, Iron, Selenium and Lipo-Glycemic Dysmetabolism in Alzheimer’s Disease

Aaseth, J., Skalny, A. V., Roos, P. M., Alexander, J., Aschner, M., & Tinkov, A. A. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22179461 · Cited by 57 · see citing works

KDM1A-mediated upregulation of METTL3 ameliorates Alzheimer's disease via enhancing autophagic clearance of p-Tau through m6A-dependent regulation of STUB1

Tang, Z., Cao, J., Yao, J.-L., Fan, X., Zhao, J., Zhao, M., Duan, Q., Han, B., & Duan, S. (2022) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2022.12.099 · Cited by 54 · see citing works

Control of mTOR Signaling by Ubiquitin

Jiang, Y., Su, S.-Y., Zhang, Y.-Q., Qian, J.-Y., & Liu, P.-D. (2019) · Oncogene · doi:10.1038/s41388-019-0713-x · Cited by 46 · see citing works

Rhodacyanine Derivative Selectively Targets Cancer Cells and Overcomes Tamoxifen Resistance

Koren, J., Miyata, Y., Kiray, J., O’Leary, J. C., Nguyen, L., Guo, J., Blair, L. J., Li, X., Jinwal, U. K., Cheng, J. Q., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0035566 · Cited by 52 · see citing works

Baicalin attenuates DDP (cisplatin) resistance in lung cancer by downregulating MARK2 and p-Akt

Xu, Z., Mei, J., & Tan, Y. (2016) · International Journal of Oncology · doi:10.3892/ijo.2016.3768 · Cited by 52 · see citing works

Proteasome‐mediated proteostasis: Novel medicinal and pharmacological strategies for diseases

Mishra, R., Upadhyay, A., Prajapati, V. K., & Mishra, A. (2018) · Medicinal Research Reviews · doi:10.1002/med.21502 · Cited by 50 · see citing works

Peripheral expression of key regulatory kinases in Alzheimer's disease and Parkinson's disease

Armentero, M., Sinforiani, E., Ghezzi, C., Bazzini, E., Levandis, G., Ambrosi, G., Zangaglia, R., Pacchetti, C., Cereda, C., Cova, E., et al. (2010) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2010.01.004 · Cited by 50 · see citing works

Cellular Responses to Misfolded Proteins and Protein Aggregates

Houck, S. A., Singh, S., & Cyr, D. (2012) · Methods in molecular biology · doi:10.1007/978-1-61779-474-2_32 · Cited by 51 · see citing works

O1‐06–03: Akt functions to regulate the chaperone complex and attenuate Tau degradation

Dickey, C. A., Koren, J., Zhang, Y., Xu, Y., Jinwal, U. K., Bailey, R. M., Dunmore, J., Birnbaum, M. J., Morgan, D., & Petrucelli, L. (2008) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2008.05.258

CHIP and Hsp70 regulate tau ubiquitination, degradation and aggregation

Petrucelli, L. (2004) · Human Molecular Genetics · doi:10.1093/hmg/ddh083 · Cited by 735 · see citing works

Phosphorylation of tau at a single residue inhibits binding to the E3 ubiquitin ligase, CHIP

Nadel, C. M., Pokhrel, S., Wucherer, K., Oehler, A., Thwin, A. C., Basu, K., Callahan, M. D., Southworth, D. R., Mordes, D. A., Craik, C. S., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-52075-1 · Cited by 36 · see citing works

P3–294: The impact of chip on neurodegenerative diseases

Petrucelli, L., Dickey, C. A., Dickson, D. W., Hutton, M., Patterson, C., & Caldwell, G. A. (2006) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2006.05.1563

Phosphorylation of a Cleaved Tau Proteoform at a Single Residue Inhibits Binding to the E3 Ubiquitin Ligase, CHIPPreprint

Nadel, C. M., Wucherer, K., Oehler, A., Thwin, A. C., Basu, K., Callahan, M. D., Southworth, D. R., Mordes, D. A., Craik, C. S., & Gestwicki, J. E. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.08.16.553575 · Cited by 1 · see citing works